Danaher (DHR) Tops Q2 EPS by 4c, Offers Q3 & FY Guidance
Get Alerts DHR Hot Sheet
Price: $207.66 --0%
Revenue Growth %: +8.4%
Financial Fact:
Earnings from continuing operations: 402.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.4%
Financial Fact:
Earnings from continuing operations: 402.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Danaher (NYSE: DHR) reported Q2 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $5.13 billion versus the consensus estimate of $5.06 billion.
Danaher sees FY2015 EPS of $4.25-$4.33, versus prior guidance of $4.23-$4.33 and the consensus of $4.28.
Danaher sees Q3 2015 EPS of $1.00-$1.04, versus the consensus of $1.05.
For earnings history and earnings-related data on Danaher (DHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Morgan Stanley Downgrades Infineon Technologies (IFX:GY) (IFNNY) to Equalweight
- Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share